Relation of HPV Infection and Oncogenes in the Cervical Cancer.
HPV 感染与宫颈癌癌基因的关系。
基本信息
- 批准号:63570788
- 负责人:
- 金额:$ 1.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1988
- 资助国家:日本
- 起止时间:1988 至 1990
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1) Filter hybridization for detection of HPV DNA was tried. Many methods and efforts were done in vain due to much contamination or vague reaction. Finally, Vira Pap kit, utilizing RNA probes, was recognized as good screening method for its clear cut reaction. The cervical cancer related lesions showed 59% positivity, whereas the healthy control showed only 2.5% positive.2) In situ hybridization was performed in paraffin slides of CIN patients. In CIN grade 1, 2, 3, HPV was detected in 64, 90 and 56% respectively. HPV Type 6/11 was 3%, type 16/18 was 44% and type 31/33/35 was 21%. Follow study of the patients revealed that cases with type 16/18 seemed to be higher risk for progression than cases with other types, and that cases with type 6/11 loosed their lesions during the period.3) Twenty four cases with the cervical cancer were studied. HPV DNA was detected by Southern blot technique in 25, 4 and 17% for type 16, 18 and related type respectively. When PCR technique was applied incidence of type 16 and 18 increased to 50 and 8% respectively. This result suggests that many cervical cancer have scanty HPV DNA, which scarcely detected by PCR method.4) In the cervical cancer expression of C-myc oncogene was noticed in 4%. Northern blot method revealed overexpression of C-myc RNA in 30%. No expression was noted concerning Ha-ras and erb B oncogenes.5) C-myc protein, ras P21 and EGFR were positive by immunohistochemistry in 8, 14 and 5% respectively. More frequent lymphnode metastasis was noticed in the ras-positive cancers.
1)尝试检测HPV DNA的过滤杂交。许多方法和努力是由于许多污染或模糊的反应而徒劳无功的。最后,利用RNA探针的Vira Pap套件被认为是其清晰切割反应的良好筛选方法。宫颈癌相关的病变显示59%的阳性,而健康的对照仅显示2.5%阳性。2)在CIN患者的石蜡片中进行原位杂交。在CIN 1、2、3中,HPV分别在64%,90%和56%中检测到HPV。 HPV 6/11型为3%,16/18型为44%,31/33/35型为21%。对患者进行的研究表明,患有16/18型的病例似乎比其他类型的病例更高,并且在此期间6/11型病例松开了病变。3)研究了二十四例宫颈癌。通过Southern印迹技术在25、4和17%的16、18和相关类型中通过Southern印迹技术检测到HPV DNA。当应用PCR技术的发生率分别为16和18时,分别增加到50和8%。该结果表明,许多宫颈癌的HPV DNA几乎没有通过PCR方法检测到。4)在c-myc癌基因的宫颈癌表达中,有4%的发现。 Northern印迹法显示C-Myc RNA的过表达为30%。没有关于HA-RAS和ERB B癌基因的表达。5)C-MYC蛋白,Ras P21和EGFR分别在8、14和5%的免疫组织化学中呈阳性。在RAS阳性癌症中发现了更频繁的淋巴转移。
项目成果
期刊论文数量(59)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
杉森 甫: "子宮頸癌の発生とその診断" 日本産科婦人科学会熊本地方部会雑誌. 34. 59-74 (1990)
Sugimori, Hajime:“宫颈癌的发病率和诊断”日本妇产科学会熊本地区分会杂志 34. 59-74 (1990)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hayashi, Y.: "Sensitivity of in situ hybridization for detection of HPV as studied in HPV type 16-transfected cells." Acta Obstet Gynaecol Jpn. 41. 2011-2012 (1989)
Hayashi, Y.:“在 HPV 16 型转染细胞中研究了原位杂交检测 HPV 的敏感性。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Iwasaka, T.: "Multi step oncogenesis by HPV and HSV." Sanfu Chiryou. 56. 696 (1988)
Iwasaka, T.:“HPV 和 HSV 导致的多步骤肿瘤发生。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hayashi,T.: "Sensitivity of insitu hybridization for detection of huma papillomavirus as studied in HPV type 16ーtransfected cells." Acta Obstet Gynaecol Japonica. 41. 2011-2012 (1989)
Hayashi, T.:“在 HPV 16 型转染细胞中研究的原位杂交检测人乳头瘤病毒的敏感性。Acta Obstet Gynaecol Japonica”,2011-2012 年。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUGIMORI Hajime其他文献
SUGIMORI Hajime的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUGIMORI Hajime', 18)}}的其他基金
Effects of hormones on Human Papilloma Virus and Telomerase activity in carcinogenesis of the cervical cancer
宫颈癌发生过程中激素对人乳头瘤病毒和端粒酶活性的影响
- 批准号:
10671554 - 财政年份:1998
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A genetherapy for the cervical cancer based on its carcinogenesis.
基于宫颈癌致癌作用的基因疗法。
- 批准号:
07671804 - 财政年份:1995
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effect of hormones on carcinogenesis of cervical cancer.
激素对宫颈癌癌变的影响。
- 批准号:
04671010 - 财政年份:1992
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Immunohistochemical study on the changes of sugar chain in cervical malignancies.
宫颈恶性肿瘤糖链变化的免疫组化研究
- 批准号:
60570784 - 财政年份:1985
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
利用新型CRISPR先导编辑工具靶向敲除HPV致癌基因的治疗新策略研发
- 批准号:32371541
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
HPV16癌基因E7调控头颈鳞癌增殖和侵袭转移的机制研究
- 批准号:81860482
- 批准年份:2018
- 资助金额:33.0 万元
- 项目类别:地区科学基金项目
基于PI3K/Akt信号靶向预防和治疗HPV E7癌基因诱导肿瘤的研究
- 批准号:81772791
- 批准年份:2017
- 资助金额:57.0 万元
- 项目类别:面上项目
宫颈癌遗传易感SNP位点相关致癌基因的筛选及功能验证
- 批准号:81402160
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
MiR-375 对HPV16/18癌基因E6/E7的调控作用及其机制
- 批准号:81272861
- 批准年份:2012
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
Dissecting NF-kB pathway in HPV-associated head and neck cancer
剖析 HPV 相关头颈癌中的 NF-kB 通路
- 批准号:
10660309 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Defining the ability of HPV oncogenes to promote mutagenesis
定义 HPV 癌基因促进突变的能力
- 批准号:
10573448 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
An investigation of how filopodia can be exploited by peptide carriers for enhanced uptake of RNAi cargo for the treatment of HPV+ oral cancers.
研究肽载体如何利用丝状伪足来增强 RNAi 货物的摄取,从而治疗 HPV 口腔癌。
- 批准号:
10678166 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
HPV genomic structure in cervical cancer radiation response and recurrence detection
HPV基因组结构在宫颈癌放射反应和复发检测中的作用
- 批准号:
10634999 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Immunomodulatory effects of topical artesunate on cervical intraepithelial neoplasia 2/3.
局部青蒿琥酯对宫颈上皮内瘤变2/3的免疫调节作用。
- 批准号:
10578829 - 财政年份:2022
- 资助金额:
$ 1.28万 - 项目类别: